Thomas Taylor, MD
Dermatology · Tampa, FLNPI 1568464931
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $15,866 of the $17,984 with a category attached, or 88.2%. It is spread thinly across 35 manufacturers, the largest accounting for just 19.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $4,108 and has fallen 52.5% since, to $1,952 in 2025.
Across 531 payments — averaging $33.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$4K
- Novartis$3K
- Incyte Corporation$2K
- Pfizer$1K
- Arcutis Biotherapeutics, Inc.$1K
- Johnson & Johnson$923
- plus $7K from 29 others
Across 233 payments — averaging $58,241 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$11.2M
- Janssen Research & Development, LLC$1.1M
- Vanda Pharmaceuticals Inc.$810K
- Eli Lilly$160K
- AbbVie$116K
- Sanofi US Services Inc.$111K
- plus $105K from 1 others
What the payments were for
- Consulting fees$1,6509%
- Food & beverage$15,86688%
- Education$4683%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 86 | $3,513 |
| Novartis | 35 | $2,587 |
| Incyte Corporation | 56 | $1,657 |
| Pfizer | 79 | $1,484 |
| Arcutis Biotherapeutics, Inc. | 35 | $1,282 |
| Johnson & Johnson | 13 | $923 |
| Galderma Laboratories, L.p. | 61 | $877 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 22 | $668 |
| Sun Pharmaceutical Industries Inc. | 16 | $633 |
| Regeneron Healthcare Solutions, Inc. | 13 | $585 |
| Lilly USA, LLC | 7 | $431 |
| Journey Medical Corporation | 10 | $369 |
| Almirall LLC | 9 | $313 |
| VYNE Pharmaceuticals Inc. | 11 | $297 |
| Dermavant Sciences, Inc. | 7 | $281 |
| Mayne Pharma Commercial LLC | 15 | $267 |
| Janssen Scientific Affairs, LLC | 2 | $248 |
| E.r. Squibb & Sons, L.L.C. | 10 | $235 |
| Sanofi | 6 | $204 |
| Botanix SB Inc | 3 | $158 |
| Paratek Pharmaceuticals, Inc. | 1 | $121 |
| UCB, Inc. | 1 | $121 |
| Novo Nordisk | 1 | $117 |
| Verrica Pharmaceuticals Inc. | 2 | $109 |
| LEO Pharma Inc. | 4 | $101 |
| Sebela Pharmaceuticals Inc. | 6 | $94 |
| Merz North America, Inc. | 1 | $86 |
| Biofrontera Inc. | 2 | $41 |
| Organon | 8 | $41 |
| Encore Dermatology Inc. | 2 | $37 |
| EPI Health, LLC | 2 | $29 |
| Dermira, Inc. | 2 | $28 |
| Boehringer Ingelheim | 1 | $23 |
| Strata Skin Sciences, Inc. | 1 | $12 |
| Amgen | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$17,984 in reported general payments places this provider in the 85th percentile of 1,147 dermatology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 46 | $1,859 |
| Desonide | 14 | $834 |
| Tacrolimus | 11 | $750 |
| Doxycycline Hyclate | 32 | $608 |
| Triamcinolone Acetonide | 43 | $338 |
| Ketoconazole | 15 | $227 |
| Mupirocin | 23 | $135 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Tampa
- Seth FormanTampa$407K
- Asha ShahTampa$332K
- Nishit PatelTampa$111K
- Francisco KerdelMiami$2.1M
- Brad GlickMargate$2M
- Robert KirsnerMiami$1.4M
- John MinniStuart$1.4M
- Gil YosipovitchMiami$1M
- Shino Bay AguileraFt Lauderdale$1M
- Robert SnyderPembroke Pines$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.